Bismuth shield affecting CT image quality and radiation dose in adjacent and distant zones relative to shielding surface: A phantom study

BACKGROUND

To quantify image quality and radiation doses in regions adjacent to and distant from bismuth shields in computed tomography (CT).

METHODS

An American College of Radiology accreditation phantom with four solid rods embedded in a water-like background was scanned to verify CT number (CTN) accuracy when using bismuth shields. CTNs, image noise, and contrast-to-noise ratios (CNRs) were determined in the phantom at 80-140 kVp. Image quality was investigated on image portions in the zones adjacent (A zone) to and distant (D zone) from a bismuth shield. Surface radiation doses were measured using thermoluminescent dosimeters. Streak artefacts were graded on a 3-point-scale.

RESULTS

Changes in CTN caused by a bismuth shield resulted in changes in X-ray spectra. CTN changes were more apparent in the A zone than in the D zone, particularly for a low tube voltage. The degrees of CTN changes and image noise were proportional to the thickness of the bismuth shields. A 1-ply bismuth shield reduced surface radiation doses by 7.2%-15.5%. The overall CNRs were slightly degraded, and streak artefacts were acceptable.

CONCLUSIONS

Using a bismuth shield could result in significant CTN changes and perceivable artefacts, particularly for a superficial organ close to the shield, and is not recommended for quantification CT examinations or follow-up CT examinations.

Targeted radiation energy modulation using Saba shielding reduces breast dose without degrading image quality during thoracic CT examinations

OBJECTIVE

Breasts dose during thoracic computed tomography examinations is a serious challenge and practical dose reduction strategies is needed. The bismuth shielding is an available method for dose reduction; however, its use is on debate due to degrading effects on image quality. The aim of this study is to explore and evaluate the efficiency of a new composition of the X-ray absorbing material to achieve a shield with a lower impact on image quality.

MATERIALS AND METHODS

Different shields were manufactured with combinations of various weight percentage of copper and bismuth. Dose reduction ratio and image quality were evaluated in phantom studies. A controlled trial with 20 female participants was conducted for image quality assessment. The shield with a lower impact on image quality, named Saba shielding, was used in the clinical trial.

RESULTS

Shielding by one (1 T) and three thickness (3 T) of the constructed shields reduced the mean entrance skin dose of breasts about 52% and 73%, respectively. The shield with a composition of 90% Cu and 10% Bi (Saba shielding) had the lowest while the shield with 100% bismuth had the highest degrading effect on image quality. The Saba shielding could provide 21% higher dose reduction than the Bi shielding at the equivalent image quality. The 1 T Saba shielding did not cause artifacts in the reconstructed images.

CONCLUSION

The Saba shielding is flexible, cheap and user-friendly for shielding breasts in thoracic CT examinations while do not have the degrading effect of the Bi shielding on image quality.

Assessment of radiation dose from abdominal quantitative CT with short scan length

OBJECTIVE

To assess radiation dose for patients who received abdominal quantitative CT and to compare the midpoint dose [D_L(0)] at the centre of a 1-cm scan length with the volume CT dose index (CTDI_vol). Although the size-specific dose estimate (SSDE) proposed in The American Association of Physicists in Medicine Report No. 204 is not applicable for short-length scans, commercial dose-monitoring software, such as Radimetrics^™ Enterprise Platform (Bayer HealthCare, Whippany, NJ), reports SSDE for all scans. SSDE was herein compared with D_L(0).

METHODS

Data were analyzed from 398 abdominal quantitative CT examinations in 165 males and 233 females. The CTDI_vol was 4.66 mGy, and the scan length was 1 cm for all examinations. Radimetrics was used to extract patient diameter and SSDE. D_L(0) was assessed using a previously reported method that takes into account both patient size and scan length.

RESULTS

The mean patient diameter was 28.5 ± 6.3 cm (range, 16.5-46.6 cm); the mean SSDE was 6.22 ± 1.36 mGy (range, 3.12-9.42 mGy); and the mean D_L(0) was 2.97 ± 0.95 mGy (range, 1.18-5.77 mGy). As patient diameter increased, the D_L(0) to CTDI_vol ratio decreased, ranging from 1.24 to 0.25; the D_L(0) to SSDE ratio also decreased, ranging from 0.61 to 0.38.

CONCLUSION

The dose to the patients from abdominal quantitative CT may be largely different from CTDI_vol and SSDE. This study demonstrates the necessity of taking into account not only patient size but also scan length for evaluating the dose from short-length scans. Advances in knowledge: In CT examinations with 1-cm scan length, dose evaluation needs to take into account both patient size and scan length. An omission of either factor can result in an erroneous result.

Radiation Doses of Various CT Protocols: a Multicenter Longitudinal Observation Study

Emerging concerns regarding the hazard from medical radiation including CT examinations has been suggested. The purpose of this study was to observe the longitudinal changes of CT radiation doses of various CT protocols and to estimate the long-term efforts of supervising radiologists to reduce medical radiation. Radiation dose data from 11 representative CT protocols were collected from 12 hospitals. Attending radiologists had collected CT radiation dose data in two time points, 2007 and 2010. They collected the volume CT dose index (CTDIvol) of each phase, number of phases, dose length product (DLP) of each phase, and types of scanned CT machines. From the collected data, total DLP and effective dose (ED) were calculated. CTDIvol, total DLP, and ED of 2007 and 2010 were compared according to CT protocols, CT machine type, and hospital. During the three years, CTDIvol had significantly decreased, except for dynamic CT of the liver. Total DLP and ED were significantly decreased in all 11 protocols. The decrement was more evident in newer CT scanners. However, there was substantial variability of changes of ED during the three years according to hospitals. Although there was variability according to protocols, machines, and hospital, CT radiation doses were decreased during the 3 years. This study showed the effects of decreased CT radiation dose by efforts of radiologists and medical society.

A Comprehensive CT Dose Reduction Program Using the ACR Dose Index Registry

PURPOSE

The purpose of this article is to demonstrate the role of the ACR Dose Index Registry(®) (DIR) in a dose reduction program at a large academic health care system.

METHODS

Using the ACR DIR, radiation doses were collected for four common CT examination types (head without contrast, chest with contrast, chest without contrast, and abdomen and pelvis with contrast). Baseline analysis of 7,255 CT examinations from seven scanners across the institution was performed for the period from December 1, 2011, to March 15, 2012. A comprehensive dose reduction initiative was guided by the identification of targets for dose improvement from the baseline analysis. Data for 14,938 examinations from the same seven scanners were analyzed for the postimplementation period of January 1, 2013, to July 1, 2013.

RESULTS

The program included protocol changes, iterative reconstruction, optimization of scan acquisition, technologist education, and continuous monitoring with feedback tools. Average decrease in median dose-length product (DLP) across scanners was 30% for chest CT without contrast, 29% for noncontrast head CT, 26% for abdominal and pelvic CT with contrast, and 10% for chest CT with contrast. Compared with average median DLP in the ACR DIR, the median institution-wide CT DLPs after implementation were lower by 33% for chest CT without contrast, 32% for chest CT with contrast, 26% for abdominal and pelvic CT with contrast, and 6% for head CT without contrast.

CONCLUSIONS

A comprehensive CT dose reduction program using the ACR DIR can lead to substantial dose reduction within a large health care system.

Qualitative and quantitative comparison of PET/CT and PET/MR imaging in clinical practice

The aim of this study was to prospectively compare whole-body PET/MR imaging and PET/CT, qualitatively and quantitatively, in oncologic patients and assess the confidence and degree of inter- and intraobserver agreement in anatomic lesion localization.

METHODS

Fifty patients referred for staging with known cancers underwent PET/CT with low-dose CT for attenuation correction immediately followed by PET/MR imaging with 2-point Dixon attenuation correction. PET/CT scans were obtained according to standard protocols (56 ± 20 min after injection of an average 367 MBq of (18)F-FDG, 150 MBq of (68)Ga-DOTATATE, or 333.8 MBq of (18)F-fluoro-ethyl-choline; 2.5 min/bed position). PET/MR was performed with 5 min/bed position. Three dual-accredited nuclear medicine physicians/radiologists identified the lesions and assigned each to an exact anatomic location. The image quality, alignment, and confidence in anatomic localization of lesions were scored on a scale of 1-3 for PET/CT and PET/MR imaging. Quantitative analysis was performed by comparing the standardized uptake values. Intraclass correlation coefficients and the Wilcoxon signed-rank test were used to assess intra- and interobserver agreement in image quality, alignment, and confidence in lesion localization for the 2 modalities.

RESULTS

Two hundred twenty-seven tracer-avid lesions were identified in 50 patients. Of these, 225 were correctly identified on PET/CT and 227 on PET/MR imaging by all 3 observers. The confidence in anatomic localization improved by 5.1% when using PET/MR imaging, compared with PET/CT. The mean percentage interobserver agreement was 96% for PET/CT and 99% for PET/MR imaging, and intraobserver agreement in lesion localization across the 2 modalities was 93%. There was 10% (5/50 patients) improvement in local staging with PET/MR imaging, compared with PET/CT.

CONCLUSION

In this first study, we show the effectiveness of whole-body PET/MR imaging in oncology. There is no statistically significant difference between PET/MR imaging and PET/CT in respect of confidence and degree of inter- and intraobserver agreement in anatomic lesion localization. The PET data on both modalities were similar; however, the observed superior soft-tissue resolution of MR imaging in head and neck, pelvis, and colorectal cancers and of CT in lung and mediastinal nodal disease points to future tailored use in these locations.

Shielding artificially increases the attenuation of water: study of CT gradient attenuation induced by shielding (CT GAINS)

RATIONALE AND OBJECTIVES

Quantitatively analyze the computed tomography (CT) attenuation effects caused by bismuth shields, which are used to reduce superficial organ dose.

MATERIALS AND METHODS

The solid water uniformity section of the American College of Radiology CT phantom was scanned with a modified chest CT protocol. Scans were performed with a bismuth breast shield in multiple configurations, emphasizing three clinically relevant orientations. Attenuation effects were measured as changes in mean Hounsfield unit (HU) values of equal midsagittal regions of interest (ROI). Multiple statistical techniques were used in regression analysis.

RESULTS

Bismuth shielding resulted in significant positive shifts of the expected Hounsfield unit values. The mean nonshielded CT attenuation was -0.16 ± 0.75 HU. Based on the clinically relevant ROI distance from the shield (~3-16 cm), the shielded values ranged from 43.8-4 HU, 45.8-10.1 HU, and 50.6-4.5 HU for shields 1, 2, and 3, respectively. All shield configurations displayed a statistically significant shift (P < .0001) at all distance ranges. The best fitting regression model was a quadratic function of distance versus logarithmic function of HU. A prediction table of the approximate shift in water HU values as a function of ROI distance from the shield was generated per shield type from their respective close-fitting regressions.

CONCLUSIONS

The data support the claim that bismuth shields increase the attenuation of water, which can cause inaccurate characterization of simple fluid, giving the appearance of complex fluid or even solid density. However, there is potential for anticipation of the attenuation effects to validate continued use of these shields for dose reduction.